Lv5
968 积分 2022-06-07 加入
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
23小时前
已完结
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
1天前
已完结
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus Erythematosus
2天前
已完结
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
4天前
已完结
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
5天前
已完结
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus
9天前
已完结
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus
9天前
已完结
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis
9天前
已完结
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
9天前
已完结
Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
10天前
已完结
皖公网安备34019202002308
